Nanocarriers can be engineered to improve the stability and efficacy of vaccines. By protecting antigens from degradation, they can enhance the immune response. For example, mRNA vaccines for COVID-19 rely on lipid nanoparticles to deliver the genetic material into cells, where it can then produce the target antigen and stimulate an immune response.
